HOME Press Releases Infertility Treatment Market worth 2.05 Billion USD by 2022



Infertility Treatment Market worth 2.05 Billion USD by 2022


The report "Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022", analyzes and studies the major market drivers, restraints, opportunities, and challenges in North America, Europe, Asia-Pacific, and the Rest of the World (RoW).

     Download PDF Brochure     Speak to Analyst     Inquiry Before Buying

Browse 70 market data tables and 56 figures spread through 169 pages and in-depth TOC on "Infertility Treatment Market by Procedure (ART, Artificial Insemination, IVF, Surrogacy, Fertility Surgery), Product (Instruments, Media, Accessories), Patient Type (Male), End User (Fertility Clinics, Hospitals, Cryobanks) - Global Forecasts to 2022"
http://www.marketsandmarkets.com/Market-Reports/infertility-treatment-devices-market-43497112.html
Early buyers will receive 10% customization on reports.

This report studies the infertility treatment market over the forecast period of 2017 to 2022. The infertility treatment market is expected to reach USD 2.05 Billion by 2022; growing at a CAGR of 10.6% during 2017 to 2022.

Based on procedure, the infertility treatment market is segmented into assisted reproductive technology (ART), artificial insemination (AI), fertility surgeries, and other procedures (including egg freezing, sperm freezing, and embryo freezing). In 2016, the ART segment accounted for the largest share of the infertility treatment market, by procedure, owing to increasing infertility and rising prevalence of lifestyle disorders (leading to decline in the fertility rate), technological innovations in the field of IVF, growing adoption of procedures like surrogacy by same-sex couples, and the high success rate of ART procedures. The ART market is further subsegmented into in vitro fertilization (IVF), and surrogacy. The IVF segment holds the largest share in the ART market. The large share of the IVF segment can be attributed to the high success rate associated with the procedure and growing awareness & social acceptance of this method.

On the basis of product, the infertility treatment market is segmented into instruments, media & consumables, and accessories. The instruments segment accounted for the largest share of the market, in 2016. The instruments segment is further sub segmented into eight products, namely, incubators, micromanipulator systems, imaging & laser systems, ovum aspiration pumps, sperm analyzers, incubators, workstations, and gas analyzers. The imaging systems product segment commanded the largest share of the instruments market in 2016, owing to factors such as increasing use of imaging systems in various infertility treatment procedures and technological advancements by key players in imaging modalities.

On the basis of patient type, the infertility treatment market is segmented into male patients and female patients. In 2016, the female patients segment accounted for the largest market share, primarily due to the decreasing female fertility rates and the availability of a wide range of treatment options.

Based on end user, the infertility treatment market is segmented into fertility centers, hospitals & clinics, research institutes, and cryobanks.

North America dominated the global infertility treatment market in 2016, followed by Europe. However, the Asia-pacific region is expected to grow at the fastest CAGR as emerging Asian countries, including China, India, South Korea, Taiwan, and Singapore, are expected to offer high growth opportunities for market players. The key factors influencing the growth of the Asia-Pacific market include a rise in medical tourism in Asian countries, rapid increase in healthcare expenditure, and continuous decline in fertility rates among the male and female population.

In 2016, The Cooper Companies Inc. (U.S.), Cook Group Incorporated (U.S.), Thermo Fisher Scientific, Inc. (U.S.), Vitrolife AB (Sweden), and Esco Micro Pte. Ltd. (Singapore) dominated the global infertility treatment market. Other prominent players include Genea Limited (Australia), IVFtech ApS (Denmark), Irvine Scientific (U.S.), and The Baker Company, Inc. (U.S.).

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 5000 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan
MarketsandMarkets™
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune, Maharashtra 411013, India
1-888-600-6441
Email: sales@marketsandmarkets.com

Connect Us

Follow us on LinkedIn  Follow us on Facebook   Follow us on Twitter 
Live Chat Support


US : 1-888-600-6441

Search reports